The IPA predisposition of individuals with CGD (and the susceptibility of CGD mice to Aspergillus challenge) indicate that products of host NADPH oxidase are required for A. fumigatus clearance from the lung (7, 8). This evidence concerns the gene FMO5 and chronic granulomatous disease.